Growing community of inventors

Southlake, TX, United States of America

Colin J Meyer

Average Co-Inventor Count = 2.00

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 204

Colin J MeyerGordon W Gribble (3 patents)Colin J MeyerMichael B Sporn (3 patents)Colin J MeyerTadashi Honda (3 patents)Colin J MeyerKaren T Liby (3 patents)Colin J MeyerRobert M Kral, Jr (3 patents)Colin J MeyerKaren Liby (3 patents)Colin J MeyerRobert M Kral (3 patents)Colin J MeyerMichael Sporn (3 patents)Colin J MeyerTadashi Honda (3 patents)Colin J MeyerWarren Huff (2 patents)Colin J MeyerJiang Zhang (2 patents)Colin J MeyerJiang Zhang (1 patent)Colin J MeyerMelanie Pei-Heng Chin (0 patent)Colin J MeyerColin J Meyer (9 patents)Gordon W GribbleGordon W Gribble (38 patents)Michael B SpornMichael B Sporn (29 patents)Tadashi HondaTadashi Honda (21 patents)Karen T LibyKaren T Liby (14 patents)Robert M Kral, JrRobert M Kral, Jr (10 patents)Karen LibyKaren Liby (3 patents)Robert M KralRobert M Kral (3 patents)Michael SpornMichael Sporn (3 patents)Tadashi HondaTadashi Honda (3 patents)Warren HuffWarren Huff (2 patents)Jiang ZhangJiang Zhang (2 patents)Jiang ZhangJiang Zhang (5 patents)Melanie Pei-Heng ChinMelanie Pei-Heng Chin (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Reata Pharmaceuticals, Inc. (7 from 61 patents)

2. Dartmouth College (3 from 676 patents)

3. Reata Pharmaceuticals Holdings, LLC (2 from 7 patents)


9 patents:

1. 11911395 - Methods of treating obesity using antioxidant inflammation modulators

2. 11446313 - Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof

3. 10953020 - Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof

4. 10105372 - Methods of treating obesity using antioxidant inflammation modulators

5. 9757359 - Synthetic triterpenoids and methods of use in the treatment of disease

6. 9155721 - Delayed release, oral dosage compositions that contain amorphous CDDO-Me

7. 8747901 - Delayed release, oral dosage compositions that contain amorphous CDDO-Me

8. 8455544 - Synthetic triterpenoids and methods of use in the treatment of disease

9. 8129429 - Synthetic triterpenoids and methods of use in the treatment of disease

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/20/2026
Loading…